A US vaccine panel recommended the human papillomavirus (HPV) vaccine for both men and women up to age 26; San Francisco has become the first city to ban e-cigarettes; the Department of Veterans Affairs (VA) is using artificial intelligence (AI) to predict which veterans are more likely to die by suicide in the next year.
A US government advisory panel said Wednesday that the human papillomavirus (HPV) vaccine should be recommended for both men and women up to age 26. Currently, men are recommended to get the vaccine until age 21. According to The Associated Press, the CDC almost always accepts the panel’s recommendations and uses them as guidance for physicians. While the vaccine is approved for people up to age 45, the Advisory Committee on Immunization Practices decided against recommending it for people older than 26 and instead issued a weak endorsement for those aged 26 to 45 years, meaning patients and their doctors can make the decision together.
San Francisco has become the first city in the United States to ban Juul and other e-cigarettes. The bill, which was praised by antitobacco advocates and the American Heart Association, also has its critics, including researchers who say that the bill might harm the wider goals of antitobacco efforts by eliminating what’s considered a safer alternative to cigarettes. According to The New York Times, merchants in the city will have 6 months to get rid of their stock. The ban will not impact the sale of conventional cigarettes or cannabis joints. City attorney and co-author of the bill Dennis Herrera said the ban would be in place until the FDA conducts a full-scale assessment of e-cigarettes.
The Department of Veterans Affairs (VA) is using artificial intelligence to determine which veterans are in need of mental health treatment. According to Politico, the computer program scans millions of records for medications, treatment, traumatic events, overall health, and other information, and, based on prior experience, picks out which veterans are more likely to die by suicide in the next year. Based on this information, clinicians then reach out to the veterans directly. Since the VA adopted the algorithms in 2017, approximately 250 fewer veterans have died by suicide; however, it’s not clear how big of a role the algorithms played in the decline.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More